A clinical-stage biotechnology company focused on developing innovative
anti-inflammatory therapies for the treatment of cardiovascular disease
fast facts
- name Cardiol Theraputics Inc.
- symbol CRDL
- exchange TSX
- financials View Filings
- shares outstanding 36,590,594 as of 04/14/2021
- industry Technology & Medical
- transfer agent Computershare Investor Services Inc.
- website https://www.cardiolrx.com
recent updates
-
Press Release -
Cardiol Therapeutics Closes $22 Million Bought Deal Offering -
-
Press Release -
IIROC Trade Resumption - CRDL -
-
most recent messages
top rated messages